These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15997664)

  • 21. [Cardiovascular gene therapy].
    Hansen PR
    Ugeskr Laeger; 1997 Nov; 159(48):7124-8. PubMed ID: 9417717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell use for cardiac diseases as of 2008.
    Ortak J; Akin I; Kische S; Nienaber CA; Ince H
    Transfus Apher Sci; 2008 Jun; 38(3):253-60. PubMed ID: 18485824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological approaches to regenerative strategies for the treatment of cardiovascular diseases.
    Pucéat M
    Curr Opin Pharmacol; 2008 Apr; 8(2):189-92. PubMed ID: 18222729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the cell cycle machinery for the treatment of cardiovascular disease.
    Bicknell KA; Surry EL; Brooks G
    J Pharm Pharmacol; 2003 May; 55(5):571-91. PubMed ID: 12831500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
    Marsboom G; Janssens S
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene and cell-based therapies for heart disease.
    Melo LG; Pachori AS; Kong D; Gnecchi M; Wang K; Pratt RE; Dzau VJ
    FASEB J; 2004 Apr; 18(6):648-63. PubMed ID: 15054087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of cardiovascular ion channels by gene therapy.
    Telemaque S; Marsh JD
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):939-53. PubMed ID: 19673672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy of cardiovascular disease.
    Nikol S
    Curr Opin Mol Ther; 2008 Oct; 10(5):479-92. PubMed ID: 18830924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy and cardiovascular disease.
    French BA
    Curr Opin Cardiol; 1998 May; 13(3):205-13. PubMed ID: 9649944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions.
    Chen XH; Minatoguchi S; Kosai K; Yuge K; Takahashi T; Arai M; Wang N; Misao Y; Lu C; Onogi H; Kobayashi H; Yasuda S; Ezaki M; Ushikoshi H; Takemura G; Fujiwara T; Fujiwara H
    J Card Fail; 2007 Dec; 13(10):874-83. PubMed ID: 18068622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botanical influences on cardiovascular disease.
    Miller AL
    Altern Med Rev; 1998 Dec; 3(6):422-31. PubMed ID: 9855567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond small molecule drugs for heart failure: prospects for gene therapy.
    Chien KR
    Novartis Found Symp; 2006; 274():244-56; discussion 256-9, 272-6. PubMed ID: 17019816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic angiogenesis with bone marrow--derived stem cells.
    Tse HF; Lau CP
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):89-97. PubMed ID: 17562779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy for heart failure.
    Nayak L; Rosengart TK
    Semin Thorac Cardiovasc Surg; 2005; 17(4):343-7. PubMed ID: 16428042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide synthase gene therapy: progress and prospects.
    O'Connor DM; O'Brien T
    Expert Opin Biol Ther; 2009 Jul; 9(7):867-78. PubMed ID: 19463074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site specific gene delivery in the cardiovascular system.
    Fishbein I; Stachelek SJ; Connolly JM; Wilensky RL; Alferiev I; Levy RJ
    J Control Release; 2005 Dec; 109(1-3):37-48. PubMed ID: 16298010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease.
    Shah PB; Losordo DW
    Adv Genet; 2005; 54():339-61. PubMed ID: 16096018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histidine button engineered into cardiac troponin I protects the ischemic and failing heart.
    Day SM; Westfall MV; Fomicheva EV; Hoyer K; Yasuda S; La Cross NC; D'Alecy LG; Ingwall JS; Metzger JM
    Nat Med; 2006 Feb; 12(2):181-9. PubMed ID: 16429145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.